“…Heterogeneity of the macrophage lineage has long been recognized (Gordon & Taylor, 2005), and they have different functional roles depending on their tissue location and the inflammatory environment that drives their activation (Davies et al ., 2013). In this context, macrophage activation has been conventionally categorized into pro‐inflammatory M1 macrophages, induced by IFN‐γ and toll‐like receptor (TLR) ligands, and the alternatively activated anti‐inflammatory M2 macrophages, induced by IL‐4/IL‐13 (Biswas & Mantovani, 2010; Gordon & Martinez, 2010). M1 are efficient producers of toxic effector molecules, pro‐inflammatory cytokines, and chemokines that kill pathogens and virus‐infected cells as well as senescent or cancer cells (Hoenicke & Zender, 2012; Davies et al ., 2013).…”